{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:42:08Z","timestamp":1776498128049,"version":"3.51.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Myocardial infarction is the leading cause of death worldwide in men and in women. Nevertheless, cardiovascular diseases in women are still understudied, underdiagnosed and undertreated leading to poor outcomes and higher mortality rates. Important sex differences exist in coronary artery disease with a higher symptom burden, delayed presentation and treatment of women in the emergency department and more non-obstructive coronary artery disease on angiogram. Sex hormones influence hemostasis and platelet function, and women suffer more from major bleeding complications after coronary interventions. Moreover, cholesterol levels increase with age particularly in women and sex hormones might play an important role in the development and progression of atherosclerosis with an increasing cardiovascular risk for women after menopause. Women also have other unique sex-specific risk factors such as hypertensive disorders of pregnancy that are contributing to an increased risk of myocardial infarction. Therefore, pharmacological therapies regarding primary or secondary prevention of coronary artery disease need to address sex differences to improve female outcome in the future. This review highlights these differences and specific risk factors in women to consider in pharmacological management of coronary artery disease.<\/jats:p>","DOI":"10.1007\/s00210-025-04751-2","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T05:43:18Z","timestamp":1761370998000},"page":"4701-4706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Sex differences in coronary artery disease"],"prefix":"10.1007","volume":"399","author":[{"given":"Lena Marie","family":"Seegers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"key":"4751_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jacc.2021.06.050","volume":"78","author":"AD Aguirre","year":"2021","unstructured":"Aguirre AD, Arbab-Zadeh A, Soeda T, Fuster V, Jang IK (2021) Optical coherence tomography of plaque vulnerability and rupture: JACC focus seminar part 1\/3. J Am Coll Cardiol 78:1257\u20131265","journal-title":"J Am Coll Cardiol"},{"key":"4751_CR2","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1097\/GME.0000000000001403","volume":"26","author":"A Ambikairajah","year":"2019","unstructured":"Ambikairajah A, Walsh E, Cherbuin N (2019) Lipid profile differences during menopause: a review with meta-analysis. Menopause 26:1327\u20131333","journal-title":"Menopause"},{"key":"4751_CR3","doi-asserted-by":"crossref","unstructured":"Ando H, Amano T, Matsubara T et al (2011) Comparison of tissue characteristics between acute coronary syndrome and stable angina pectoris. An integrated backscatter intravascular ultrasound analysis of culprit and non-culprit lesions. Circ J 75:383\u2013390","DOI":"10.1253\/circj.CJ-10-0815"},{"issue":"2","key":"4751_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11239-020-02220-6","volume":"51","author":"M Araki","year":"2021","unstructured":"Araki M, Yonetsu T, Kurihara O et al (2021) Circadian variations in pathogenesis of ST-segment elevation myocardial infarction: an optical coherence tomography study. J Thromb Thrombolysis 51(2):379\u2013387","journal-title":"J Thromb Thrombolysis"},{"issue":"10","key":"4751_CR5","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41569-022-00687-9","volume":"19","author":"M Araki","year":"2022","unstructured":"Araki M, Park SJ, Dauerman HL et al (2022) Optical coherence tomography in coronary atherosclerosis assessment and intervention. Nat Rev Cardiol 19(10):684\u2013703","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"4751_CR6","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.hlc.2017.02.023","volume":"27","author":"PR Barr","year":"2018","unstructured":"Barr PR, Harrison W, Smyth D, Flynn C, Lee M, Kerr AJ (2018) Myocardial infarction without obstructive coronary artery disease is not a benign condition (ANZACS-QI 10). Heart Lung Circ 27(2):165\u2013174","journal-title":"Heart Lung Circ"},{"key":"4751_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1001\/jama.295.12.1420","volume":"295","author":"DM Becker","year":"2006","unstructured":"Becker DM, Segal J, Vaidya D, Yanek LR, Herrera-Galeano JE, Bray PF, Moy TF, Becker LC, Faraday N (2006) Sex differences in platelet reactivity and response to low-dose aspirin therapy. JAMA 295:1420\u20131427","journal-title":"JAMA"},{"issue":"9","key":"4751_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1001\/jamacardio.2024.1712","volume":"9","author":"CP Benziger","year":"2024","unstructured":"Benziger CP, Stebbins A, Wruck LM, Effron MB, Marquis-Gravel G, Farrehi PM, Girotra S, Gupta K, Kripalani S, Munoz D, Polonsky TS, Sharlow A, Whittle J, Harrington RA, Rothman RL, Hernandez AF, Jones WS (2024) Aspirin dosing for secondary prevention of atherosclerotic cardiovascular disease in male and female patients: A secondary analysis of the ADAPTABLE randomized clinical trial. JAMA Cardiol 9(9):808\u2013816","journal-title":"JAMA Cardiol"},{"issue":"1","key":"4751_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.numecd.2023.09.023","volume":"34","author":"M Berteotti","year":"2024","unstructured":"Berteotti M, Profili F, Nreu B, Casolo G, Zuppiroli A, Mannucci E, Marcucci R, Francesconi P (2024) LDL-cholesterol target levels achievement in high-risk patients: an (un)expected gender bias. Nutr Metab Cardiovasc Dis 34(1):145\u2013152","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"4751_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s12471-011-0189-y","volume":"19","author":"NJ Breet","year":"2011","unstructured":"Breet NJ, Sluman MA, van Berkel MA, van Werkum JW, Bouman HJ, Harmsze AM, Kelder JC, Zijlstra F, Hackeng CM, Ten Berg JM (2011) Effect of gender difference on platelet reactivity. Neth Heart J 19(11):451\u2013457","journal-title":"Neth Heart J"},{"issue":"8","key":"4751_CR11","doi-asserted-by":"publisher","first-page":"e005968","DOI":"10.1161\/JAHA.117.005968","volume":"6","author":"R Bugiardini","year":"2017","unstructured":"Bugiardini R, Ricci B, Cenko E, Vasiljevic Z, Kedev S, Davidovic G, Zdravkovic M, Mili\u010di\u0107 D, Dilic M, Manfrini O, Koller A, Badimon L (2017) Delayed care and mortality among women and men with myocardial infarction. J Am Heart Assoc 6(8):e005968","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"4751_CR12","doi-asserted-by":"publisher","first-page":"e012447","DOI":"10.1161\/CIRCINTERVENTIONS.122.012447","volume":"16","author":"SN Burgess","year":"2023","unstructured":"Burgess SN, Shoaib A, Sharp ASP, Ludman P, Graham MM, Figtree GA, Kontopantelis E, Rashid M, Kinnaird T, Mamas MA (2023) Sex-specific differences in potent P2Y12 inhibitor use in British Cardiovascular Intervention Society registry STEMI patients. Circ Cardiovasc Interv 16(9):e012447","journal-title":"Circ Cardiovasc Interv"},{"key":"4751_CR13","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1067\/mhj.2001.109946","volume":"141","author":"AP Burke","year":"2001","unstructured":"Burke AP, Farb A, Malcom G, Virmani R (2001) Effect of menopause on plaque morphologic characteristics in coronary atherosclerosis. Am Heart J 141:S58-62","journal-title":"Am Heart J"},{"key":"4751_CR14","doi-asserted-by":"crossref","unstructured":"Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372(25):2387\u20132397","DOI":"10.1056\/NEJMoa1410489"},{"issue":"7","key":"4751_CR15","doi-asserted-by":"publisher","first-page":"e014611","DOI":"10.1161\/JAHA.119.014611","volume":"9","author":"R Chandiramani","year":"2020","unstructured":"Chandiramani R, Cao D, Claessen BE, Sorrentino S, Guedeney P, Blum M, Goel R, Roumeliotis A, Krucoff M, Kozuma K, Ge J, Seth A, Makkar R, Bangalore S, Bhatt DL, Angiolillo DJ, Ruster K, Wang J, Saito S, Neumann FJ, Hermiller J, Valgimigli M, Mehran R (2020) Sex-related differences in patients at high bleeding risk undergoing percutaneous coronary intervention: a patient-level pooled analysis from 4 postapproval studies. J Am Heart Assoc 9(7):e014611","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"4751_CR16","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1111\/j.1525-1497.2005.00252.x","volume":"20","author":"KB DeSalvo","year":"2005","unstructured":"DeSalvo KB, Gregg J, Kleinpeter M, Pedersen BR, Stepter A, Peabody J (2005) Cardiac risk underestimation in urban, black women. J Gen Intern Med 20(12):1127\u20131131","journal-title":"J Gen Intern Med"},{"key":"4751_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","volume":"34","author":"E Falk","year":"2013","unstructured":"Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R (2013) Update on acute coronary syndromes: the pathologists\u2019 view. Eur Heart J 34:719\u2013728","journal-title":"Eur Heart J"},{"key":"4751_CR18","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1161\/01.CIR.103.7.993","volume":"103","author":"Y Fukumoto","year":"2001","unstructured":"Fukumoto Y, Libby P, Rabkin E et al (2001) Statins alter smooth muscle cell accumulation and collagen content in established atheroma of Watanabe heritable hyperlipidemic rabbits. Circulation 103:993\u2013999","journal-title":"Circulation"},{"key":"4751_CR19","doi-asserted-by":"crossref","unstructured":"GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 396:1204\u201322","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"23","key":"4751_CR20","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.jacc.2022.03.381","volume":"79","author":"MG Hauge","year":"2022","unstructured":"Hauge MG, Damm P, Kofoed KF, Ersb\u00f8ll AS, Johansen M, Sigvardsen PE, M\u00f8ller MB, Fuchs A, K\u00fchl JT, Nordestgaard BG, K\u00f8ber LV, Gustafsson F, Linde JJ (2022) Early coronary atherosclerosis in women with previous preeclampsia. J Am Coll Cardiol 79(23):2310\u20132321","journal-title":"J Am Coll Cardiol"},{"key":"4751_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.jcin.2015.02.026","volume":"8","author":"T Higuma","year":"2015","unstructured":"Higuma T, Soeda T, Abe N et al (2015) Combined Optical coherence tomography and intravascular ultrasound study on plaque rupture, plaque erosion, and calcified nodule in patients with ST-segment elevation myocardial infarction: incidence, morphologic characteristics, and outcomes after percutaneous coronary intervention. JACC Cardiovasc Interv 8:1166\u20131176","journal-title":"JACC Cardiovasc Interv"},{"issue":"24","key":"4751_CR22","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1001\/jama.2019.19191","volume":"322","author":"MC Honigberg","year":"2019","unstructured":"Honigberg MC, Zekavat SM, Aragam K, Finneran P, Klarin D, Bhatt DL, Januzzi JL Jr, Scott NS, Natarajan P (2019) Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. JAMA 322(24):2411\u20132421","journal-title":"JAMA"},{"issue":"7","key":"4751_CR23","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/CIRCULATIONAHA.120.047936","volume":"142","author":"MC Honigberg","year":"2020","unstructured":"Honigberg MC, Chaffin M, Aragam K et al (2020) Genetic variation in cardiometabolic traits and medication targets and the risk of hypertensive disorders of pregnancy. Circulation 142(7):711\u2013713","journal-title":"Circulation"},{"issue":"4","key":"4751_CR24","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.jacl.2016.02.016","volume":"10","author":"DG Karalis","year":"2016","unstructured":"Karalis DG, Wild RA, Maki KC, Gaskins R, Jacobson TA, Sponseller CA, Cohen JD (2016) Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol 10(4):833\u2013841","journal-title":"J Clin Lipidol"},{"issue":"4","key":"4751_CR25","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/CIRCIMAGING.112.973701","volume":"5","author":"K Kato","year":"2012","unstructured":"Kato K, Yonetsu T, Kim SJ et al (2012) Nonculprit plaques in patients with acute coronary syndromes have more vulnerable features compared with those with non-acute coronary syndromes: a 3-vessel optical coherence tomography study. Circ Cardiovasc Imaging 5(4):433\u2013440","journal-title":"Circ Cardiovasc Imaging"},{"issue":"11","key":"4751_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006901","volume":"6","author":"ET Kato","year":"2017","unstructured":"Kato ET, Cannon CP, Blazing MA, Bohula E, Guneri S, White JA, Murphy SA, Park JG, Braunwald E, Giugliano RP (2017) Efficacy and safety of adding ezetimibe to statin therapy among women and men: insight from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial). J Am Heart Assoc 6(11):e006901","journal-title":"J Am Heart Assoc"},{"key":"4751_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1540-8183.2010.00598.x","volume":"23","author":"MA Khuddus","year":"2010","unstructured":"Khuddus MA, Pepine CJ, Handberg EM, Bairey Merz CN, Sopko G, Bavry AA, Denardo SJ, McGorray SP, Smith KM, Sharaf BL et al (2010) An intravascular ultrasound analysis in women experiencing chest pain in the absence of obstructive coronary artery disease: a substudy from the National Heart, Lung and Blood Institute-sponsored Women\u2019s Ischemia Syndrome Evaluation (WISE). J Interv Cardiol 23:511\u2013519","journal-title":"J Interv Cardiol"},{"key":"4751_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.03.058","author":"AS Kini","year":"2013","unstructured":"Kini AS, Baber U, Kovacic JC, Limaye A, Ali ZA, Sweeny J, Maehara A, Mehran R, Dangas G, Mintz GS, Fuster V, Narula J, Sharma SK, Moreno PR (2013) Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2013.03.058","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"4751_CR29","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.jcin.2025.01.424","volume":"18","author":"V Kunadian","year":"2025","unstructured":"Kunadian V, Gitto M, Vogel B, Sartori S, Angiolillo DJ, Bhatt DL, Chehab BM, Feng Y, de la Torre Hernandez JM, Krucoff MW, Maksoud A, Mankerious N, Oliva A, Picon H, Richardt G, Sardella G, Thiele H, Toelg R, Varenne O, Vranckx P, Windecker S, Valgimigli M, Mehran R (2025) 1-month or 3-month DAPT in women and men at high bleeding risk undergoing PCI. JACC Cardiovasc Interv 18(7):866\u2013878","journal-title":"JACC Cardiovasc Interv"},{"key":"4751_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/0002-8703(86)90155-9","volume":"111","author":"DJ Lerner","year":"1986","unstructured":"Lerner DJ, Kannel WB (1986) Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111:383\u2013390","journal-title":"Am Heart J"},{"issue":"5 Pt 1","key":"4751_CR31","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1161\/01.CIR.78.5.1157","volume":"78","author":"WC Little","year":"1988","unstructured":"Little WC, Constantinescu M, Applegate RJ et al (1988) Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78(5 Pt 1):1157\u20131166","journal-title":"Circulation"},{"issue":"8","key":"4751_CR32","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1161\/CIR.0000000000001303","volume":"151","author":"SS Martin","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM et al (2025) 2025 heart disease and stroke statistics: a report of US and Global data from the American Heart Association. Circulation 151(8):e41\u2013e660","journal-title":"Circulation"},{"key":"4751_CR33","doi-asserted-by":"crossref","unstructured":"Martinho M, Cal\u00e9 R, Briosa A, Pereira E, Pereira AR, Ferreira B, Vitorino S, Santos P, Morgado J, Eus\u00e9bio C, Ara\u00fajo P, Morgado G, Martins C, Pereira H (2025) Awareness for the risk of adverse outcomes of female patients after ST-segment elevation acute coronary syndrome. Cardiovasc Revasc Med S1553\u20138389(25):00019\u201300023","DOI":"10.1016\/j.carrev.2025.01.006"},{"key":"4751_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10557-015-6596-3","volume":"29","author":"P Mathur","year":"2015","unstructured":"Mathur P, Ostadal B, Romeo F, Mehta JL (2015) Gender-related differences in atherosclerosis. Cardiovasc Drugs Ther 29:319\u2013327","journal-title":"Cardiovasc Drugs Ther"},{"key":"4751_CR35","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","volume":"133","author":"LS Mehta","year":"2016","unstructured":"Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE et al (2016) Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation 133:916\u2013947","journal-title":"Circulation"},{"key":"4751_CR36","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH (1999) The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801\u20131811","journal-title":"N Engl J Med"},{"key":"4751_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-3-319-04981-6_24","volume":"120","author":"E Nevzati","year":"2015","unstructured":"Nevzati E, Shafighi M, Bakhtian KD, Treiber H, Fandino J, Fathi AR (2015) Estrogen induces nitric oxide production via nitric oxide synthase activation in endothelial cells. Acta Neurochir Suppl 120:141\u2013145","journal-title":"Acta Neurochir Suppl"},{"key":"4751_CR38","doi-asserted-by":"crossref","unstructured":"Nissen SE, Lincoff AM, Brennan D, Ray KK, Mason D, Kastelein JJP, Thompson PD, Libby P, Cho L, Plutzky J, Bays HE, Moriarty PM, Menon V, Grobbee DE, Louie MJ, Chen CF, Li N, Bloedon L, Robinson P, Horner M, Sasiela WJ, McCluskey J, Davey D, Fajardo-Campos P, Petrovic P, Fedacko J, Zmuda W, Lukyanov Y, Nicholls SJ (2023) CLEAR Outcomes Investigators. Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients. N Engl J Med 388(15):1353\u20131364","DOI":"10.1056\/NEJMoa2215024"},{"issue":"4","key":"4751_CR39","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0024-3205(01)01131-6","volume":"69","author":"MG O'Sullivan","year":"2001","unstructured":"O\u2019Sullivan MG, Goodrich JA, Adams MR (2001) Increased prostacyclin synthesis by atherosclerotic arteries from estrogen-treated monkeys. Life Sci 69(4):395\u2013401","journal-title":"Life Sci"},{"key":"4751_CR40","doi-asserted-by":"crossref","unstructured":"Paradies V, Masiero G, Rubboli A, Van Beusekom HMM, Costa F, Capranzano P, Degrauwe S, Gorog DA, Jorge CM, Buchanan GL, Alasnag M, Trabattoni D, Fraccaro C, Sibbing D, Dudek D, Vilahur G, Chieffo A, Mehran R, Capodanno D, Barbato E, Siller-Matula JM (2025) Antithrombotic drugs for acute coronary syndromes in women: sex-adjusted treatment and female representation in randomised clinical trials. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the ESC Working Group on Thrombosis. EuroIntervention 21(12):e655\u2013e667","DOI":"10.4244\/EIJ-D-24-00876"},{"issue":"16","key":"4751_CR41","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jacc.2018.02.032","volume":"71","author":"SAE Peters","year":"2018","unstructured":"Peters SAE, Colantonio LD, Zhao H, Bittner V, Dai Y, Farkouh ME, Monda KL, Safford MM, Muntner P, Woodward M (2018) Sex differences in high-intensity statin use following myocardial infarction in the United States. J Am Coll Cardiol 71(16):1729\u20131737","journal-title":"J Am Coll Cardiol"},{"key":"4751_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.atherosclerosis.2021.02.024","volume":"324","author":"Y Rachamin","year":"2021","unstructured":"Rachamin Y, Grischott T, Rosemann T, Meyer MR (2021) Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: a large-scale, cross-sectional study in primary care. Atherosclerosis 324:141\u2013147","journal-title":"Atherosclerosis"},{"key":"4751_CR43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1001\/jamacardio.2020.0822","volume":"5","author":"HR Reynolds","year":"2020","unstructured":"Reynolds HR, Shaw LJ, Min JK, Spertus JA, Chaitman BR, Berman DS, Picard MH et al (2020) Association of sex with severity of coronary artery disease, ischemia, and symptom burden in patients with moderate or severe ischemia: secondary analysis of the ISCHEMIA randomized clinical trial. JAMA Cardiol 5:773\u2013786","journal-title":"JAMA Cardiol"},{"issue":"7","key":"4751_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.120.052008","volume":"143","author":"HR Reynolds","year":"2021","unstructured":"Reynolds HR, Maehara A, Kwong RY et al (2021) Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation 143(7):624\u2013640","journal-title":"Circulation"},{"key":"4751_CR45","doi-asserted-by":"crossref","unstructured":"Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359(21):2195\u2013207","DOI":"10.1056\/NEJMoa0807646"},{"issue":"22","key":"4751_CR46","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","volume":"391","author":"PM Ridker","year":"2024","unstructured":"Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE (2024) Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women. N Engl J Med 391(22):2087\u20132097. https:\/\/doi.org\/10.1056\/NEJMoa2405182","journal-title":"N Engl J Med"},{"issue":"9","key":"4751_CR47","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.jacadv.2023.100669","volume":"2","author":"FB Rivera","year":"2023","unstructured":"Rivera FB, Cha SW, Aparece JP, Rocimo A, Ong BA, Golbin JM, Alfonso PG, Enkhmaa B, Khan SU, Cainzos-Achirica M, Volgman AS, Navar AM, Shah NP (2023) Sex differences in cardiovascular outcomes and cholesterol-lowering efficacy of PCSK9 inhibitors: systematic review and meta-analysis. JACC Adv 2(9):100669","journal-title":"JACC Adv"},{"key":"4751_CR48","doi-asserted-by":"crossref","unstructured":"Schwartz GG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM, ODYSSEY OUTCOMES Committees and Investigators (2018) Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med 379(22):2097\u20132107","DOI":"10.1056\/NEJMoa1801174"},{"issue":"25","key":"4751_CR49","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration (2021) SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J 42(25):2439\u20132454","journal-title":"Eur Heart J"},{"key":"4751_CR50","doi-asserted-by":"publisher","first-page":"e011612","DOI":"10.1161\/CIRCINTERVENTIONS.121.011612","volume":"15","author":"LM Seegers","year":"2022","unstructured":"Seegers LM, Araki M, Nakajima A, Yonetsu T, Minami Y, Ako J et al (2022) Sex differences in culprit plaque characteristics among different age groups in patients with acute coronary syndromes. Circ Cardiovasc Interv 15:e011612","journal-title":"Circ Cardiovasc Interv"},{"key":"4751_CR51","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.amjcard.2023.08.152","volume":"207","author":"LM Seegers","year":"2023","unstructured":"Seegers LM, Yeh DD, Wood MJ, Yonetsu T, Minami Y, Araki M, Nakajima A, Yuki H, Ako J, Soeda T, Kurihara O, Higuma T, Kimura S, Adriaenssens T, Nef HM, Lee H, McNulty I, Sugiyama T, Kakuta T, Jang IK (2023) Cardiovascular risk factors and culprit plaque characteristics in women with acute coronary syndromes. Am J Cardiol 207:13\u201320","journal-title":"Am J Cardiol"},{"key":"4751_CR52","doi-asserted-by":"publisher","unstructured":"Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG (2002) Prospective study of pravastatin in elderly individuals at risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360(9346):1623\u20131630. https:\/\/doi.org\/10.1016\/s0140-6736(02)11600-x","DOI":"10.1016\/s0140-6736(02)11600-x"},{"key":"4751_CR53","doi-asserted-by":"publisher","first-page":"152","DOI":"10.15344\/2456-8007\/2020\/152","volume":"5","author":"LR Smith","year":"2020","unstructured":"Smith LR, Salifu MO, McFarlane IM (2020) Non-obstructive coronary artery disease in women: current evidence and future directions. Int J Clin Res Trials 5:152","journal-title":"Int J Clin Res Trials"},{"issue":"3","key":"4751_CR54","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin OP, Mattison DR (2009) Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 48(3):143\u2013157","journal-title":"Clin Pharmacokinet"},{"issue":"18","key":"4751_CR55","doi-asserted-by":"publisher","first-page":"e891","DOI":"10.1161\/CIR.0000000000000670","volume":"139","author":"JE Tamis-Holland","year":"2019","unstructured":"Tamis-Holland JE, Jneid H, Reynolds HR et al (2019) Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation 139(18):e891\u2013e908","journal-title":"Circulation"},{"key":"4751_CR56","doi-asserted-by":"crossref","unstructured":"Van Oortmerssen JAE, Mulder JWCM, van der Bijl MF, Mijnster RJM, Kavousi M, Roeters van Lennep JE, IMPRESS consortium (2025) Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women. Curr Atheroscler Rep 27(1):29","DOI":"10.1007\/s11883-025-01275-1"},{"key":"4751_CR57","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1161\/01.ATV.20.5.1262","volume":"20","author":"R Virmani","year":"2000","unstructured":"Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 20:1262\u20131275","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8 Suppl","key":"4751_CR58","doi-asserted-by":"publisher","first-page":"C13","DOI":"10.1016\/j.jacc.2005.10.065","volume":"47","author":"R Virmani","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD (2006) Pathology of the vulnerable plaque. J Am Coll Cardiol 47(8 Suppl):C13\u2013C18","journal-title":"J Am Coll Cardiol"},{"key":"4751_CR59","doi-asserted-by":"crossref","unstructured":"Vogel B, Acevedo M, Appelman Y, Bairey Merz CN, Chieffo A, Figtree GA, Guerrero M, Kunadian V, Lam CSP, Maas AHEM, Mihailidou AS, Olszanecka A, Poole JE, Saldarriaga C, Saw J, Z\u00fchlke L, Mehran R (2021) The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 397(10292):2385\u20132438","DOI":"10.1016\/S0140-6736(21)00684-X"},{"issue":"3","key":"4751_CR60","first-page":"165","volume":"38","author":"WT Wang","year":"2017","unstructured":"Wang WT, James SK, Wang TY (2017) A review of sex-specific benefits and risks of antithrombotic therapy in acute coronary syndrome. Eur Heart J 38(3):165\u2013171","journal-title":"Eur Heart J"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-025-04751-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-025-04751-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T07:01:46Z","timestamp":1776495706000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-025-04751-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["4751"],"URL":"https:\/\/doi.org\/10.1007\/s00210-025-04751-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics, consent to participate"}},{"value":"The author did not receive support from any organization for the submitted work. Financial interests: The author received educational grants by Abbott Vascular and Terumo Europe and obtained honoraria for lectures by Daiichi Sankyo, Pfizer and Bristol-Meyers Sqibb.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}